LUMC
Funder
665 Projects, page 1 of 133
assignment_turned_in Project2008 - 2011Partners:INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, ERASMUS MC, AAU, Governo Italiano, deCODE Genetics (Iceland) +53 partnersINSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE,ERASMUS MC,AAU,Governo Italiano,deCODE Genetics (Iceland),VITRO S.A.,ISCIII,University of Turku,LSGi,GENOMA ESPAÑA,University of Manchester,MMI,ACC,GENERAL SECRETARIAT FOR RESEARCH AND INNOVATION,MUG,INCA,University of Salamanca,MPG,Helmholtz Zentrum München,MERIEUX ALLIANCE SA,ZON,IPPOSI,THL,HRB,Academy of Athens,Uppsala University,MRC,BMBF,UMCG,USMI,HARIDUS-JA TEADUS MINISTEERIUM,UK Biobank,LUMC,KI,LEGAL PATHWAYS BV,BBT,Telethon Foundation,University of Malta,USMI,FHF,MINISTERIE VAN ONDERWIJS, CULTUUR EN WETENSCHAP,IARC,BIOMEDICAL RESEARCH FOUNDATION, ACADEMY OF ATHENS,WHO,BUNDESMINISTERIUM FUR WISSENSCHAFT UND FORSCHUNG BMWF,iPRI,RANNIS,NTNU,HGFHELMHOLTZ ASSOCIATION OF GERMAN RESEARCH CENTRE,EMBL,NIPH,Semmelweis University,Cardiff University,CNR,UT,NEDERLANDSE FEDERATIE VAN UNIVERSITAIR MEDISCH CENTRA,Presidenza Del Consiglio Dei Ministri,FHGFunder: European Commission Project Code: 212111more_vert assignment_turned_in Project2013 - 2016Partners:KCL, Philips GmbH, LUMC, UCL, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE +2 partnersKCL,Philips GmbH,LUMC,UCL,INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE,FUNDACAO CHAMPALIMAU,INESC TECFunder: European Commission Project Code: 600948more_vert Open Access Mandate for Publications assignment_turned_in Project2012 - 2017Partners:KLINIKUM DER UNIVERSITAET ZU KOELN, ARIADNE, Newcastle University, Helmholtz Association of German Research Centres, VIB +17 partnersKLINIKUM DER UNIVERSITAET ZU KOELN,ARIADNE,Newcastle University,Helmholtz Association of German Research Centres,VIB,THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE,BIO-PRODICT BV,UWA,LUMC,Agilent Technologies (Sweden),University of Tübingen,UCL,INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE,University Medical Center Freiburg,PROFILOMIC,DZG,Agilent Technologies (United States),deCODE Genetics (Iceland),University of Ferrara,DZNE,AMU,UNIMIFunder: European Commission Project Code: 305121more_vert Open Access Mandate for Publications assignment_turned_in Project2016 - 2021Partners:Lund University, Janssen (Belgium), STICHTING AMSTERDAM UMC, UCPH, UniPi +25 partnersLund University,Janssen (Belgium),STICHTING AMSTERDAM UMC,UCPH,UniPi,ULB,University of Dundee,Imperial,Université Paris Diderot,INSTITUT DE RECHERCHES SERVIER,TUD,CNRS,University of Tübingen,INSERM,UEF,UMCG,LUMC,UOXF,Johnson & Johnson (United States),SANOFI-AVENTIS DEUTSCHLAND GMBH,Centre Hospitalier Régional et Universitaire de Lille,LIPOTYPE,UNIL,Novo Nordisk,SIB,Azienda Ospedaliera Citta' Della Salute E Della Scienza Di Torino,University of Groningen,University of Paris,SCIENTIFIC PROJECT MANAGEMENT,Eli Lilly and Company LimitedFunder: European Commission Project Code: 115881Overall Budget: 18,691,100 EURFunder Contribution: 8,130,000 EURThe stated goal of RHAPSODY is to define a molecular taxonomy of type 2 diabetes mellitus (T2D) that will support patient segmentation, inform clinical trial design, and the establishment of regulatory paths for the adoption of novel strategies for diabetes prevention and treatment. To address these goals, RHAPSODY will bring together prominent European experts, including the leaders of the diabetes-relevant IMI1 projects to identify, validate and characterize causal biomarkers for T2D subtypes and progression. Our plans are built upon: (a) access to large European cohorts with comprehensive genetic analyses and rich longitudinal clinical and biochemical data and samples; (b) detailed multi-omic maps of key T2D-relevant tissues and organs; (c) large expertise in the development and use of novel genetic, epigenetic, biochemical and physiological experimental approaches; (d) the ability to combine existing and novel data sets through effective data federation and use of these datasets in systems biology approaches towards precision medicine; and (e) expertise in regulatory approval, health economics and patient engagement. These activities will lead to the discovery of novel biomarkers for improved T2D taxonomy, to support development of pharmaceutical activities, and for use in precision medicine to improve health in Europe and worldwide.
more_vert Open Access Mandate for Publications assignment_turned_in Project2010 - 2015Partners:PENN, KCL, FBK, UKA, TU Delft +8 partnersPENN,KCL,FBK,UKA,TU Delft,PHILIPS ELECTRONICS NEDERLAND B.V.,LUMC,Heidelberg University,Philips GmbH,EPFL,IMINDS,MSE,TECHNOLUTION B.V.Funder: European Commission Project Code: 241711more_vert
chevron_left - 1
- 2
- 3
- 4
- 5
chevron_right